XRF SCIENTIFIC LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.295 AUD | +5.28% |
|
-5.47% | +9.75% |
| Apr. 16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
| Feb. 20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Ratings chart - Surperformance
Sector: Office Equipment
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +9.75% | 112M | - | ||
| +21.44% | 27.62B | A- | ||
| +31.06% | 4.78B | B+ | ||
| +19.62% | 1.72B | A- | ||
| +3.22% | 1.05B | - | - | |
| +23.18% | 1.02B | B | ||
| -22.41% | 1.01B | - | ||
| -43.58% | 797M | - | ||
| -1.42% | 437M | - | ||
| -14.20% | 342M | B- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- XRF Stock
- Ratings XRF Scientific Limited
